Peibin Yue Selected Research

Peibin Yue Research Topics

Disease

15	Neoplasms (Cancer) 01/2023 - 08/2009
6	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 02/2016 - 05/2010
3	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2012
3	Triple Negative Breast Neoplasms 12/2022 - 10/2020
3	Glioma (Gliomas) 02/2016 - 09/2015
2	Multiple Myeloma 01/2024 - 08/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 02/2012
2	Carcinogenesis 01/2022 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 02/2012
2	Leukemia 09/2015 - 02/2012
2	Hypertension (High Blood Pressure) 05/2009 - 10/2008
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Colitis-Associated Neoplasms 01/2019
1	Colitis 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Shock 09/2015
1	Cardiomegaly (Heart Hypertrophy) 05/2009
1	Type 2 Diabetes Mellitus (MODY) 02/2009
1	Insulin Resistance 02/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2010
5	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 06/2012 - 05/2010
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 05/2010
3	Tyrosine (L-Tyrosine)FDA Link 01/2022 - 09/2015
3	Particulate MatterIBA 02/2009 - 01/2008
2	Janus KinasesIBA 01/2022 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 09/2011
2	Epidermal Growth Factor (EGF)IBA 09/2015 - 05/2011
2	SurvivinIBA 09/2015 - 06/2012
2	Cyclin D1IBA 09/2015 - 06/2012
2	Peptides (Polypeptides)IBA 06/2012 - 03/2011
1	Single-Chain AntibodiesIBA 03/2024
1	tyrosine receptor (receptor, tyrosine)IBA 03/2024
1	Phosphotransferases (Kinase)IBA 03/2024
1	Ephrin-B2 (Ephrin B2)IBA 01/2024
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	NADP (NADPH)IBA 12/2022
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2022
1	Thioredoxin-Disulfide ReductaseIBA 12/2022
1	azetidineIBA 01/2022
1	LigandsIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	ChromatinIBA 10/2020
1	Phenobarbital (Luminal)FDA Link 10/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2020
1	Estrogen Receptor alphaIBA 10/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2019
1	Dextran SulfateIBA 01/2019
1	AzoxymethaneIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2017
1	ezrinIBA 01/2017
1	Neurofibromin 2 (Merlin)IBA 01/2017
1	Benzoic Acid (Potassium Benzoate)FDA Link 02/2016
1	Hydroxamic Acids (Hydroxamic Acid)IBA 02/2016
1	Karyopherins (Importin)IBA 10/2015
1	VimentinIBA 10/2015
1	microtubule-associated protein 1B (MAP5)IBA 10/2015
1	ResveratrolIBA 09/2015
1	Sirolimus (Rapamycin)FDA Link 09/2015
1	Serine (L-Serine)FDA Link 09/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2015
1	CaspasesIBA 09/2015
1	Acetates (Acetic Acid Esters)FDA Link 09/2015
1	Cyclin B1IBA 09/2015
1	BP-1-102IBA 06/2012
1	Cadherins (E-Cadherin)IBA 06/2012
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 06/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2012
1	Macrophage Migration-Inhibitory FactorsIBA 06/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2012
1	Factor VIII (Coagulation Factor VIII)IBA 06/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012
1	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2012
1	PaxillinIBA 06/2012
1	immunoglobulin-binding factorsIBA 06/2012
1	STAT5 Transcription FactorIBA 02/2012
1	Cyclin D2IBA 02/2012
1	PeptidomimeticsIBA 03/2011
1	2- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazineIBA 03/2011
1	PurinesIBA 01/2011
1	purineIBA 01/2011
1	PhosphotyrosineIBA 05/2010
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 08/2009
1	rho-Associated KinasesIBA 05/2009
1	CollagenIBA 05/2009
1	fasudil (AT 877)IBA 05/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2009
1	Protein Kinase CIBA 02/2009

Therapy/Procedure

3	Therapeutics 10/2020 - 05/2010
2	Drug Therapy (Chemotherapy) 03/2024 - 01/2022
1	Immunotherapy 01/2023
1	Molecular Targeted Therapy 01/2023